Abbott has voluntarily recalled one batch (No. AEJ0713; Mfg. Date: March 2023) of Thyronorm, a medicine used in the treatment of hypothyroidism, in India, due to a labeling error that mislabeled the dose strength (mcg or microgram). We haven’t received any reports of patient impact.
We have also set up a helpline to address any queries or concerns of patients and the medical community. For any information or guidance, please contact Abbott at: +91 22 50461000 / 50462000 or webmasterindia@abbott.com
Published on April 27, 2023
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
FOLLOW ABBOTT